Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
JAMA
|
January 22, 2025
Risankizumab for Ulcerative Colitis-Reply
Edouard Louis, Jasmina Kalabic, Edward V Loftus
Journal of Comparative Effectiveness Research
|
August 22, 2018
Systematic review and network meta-analysis: effect of biologics on radiographic progression in rheumatoid arthritis
Erin Murray, Alexandra Ellis, Yekaterina Butylkova, et al.
Clinical Pharmacokinetics
|
December 20, 2024
Evaluation of the Effect of Risankizumab on the Pharmacokinetics of Cytochrome P450 Substrates in Patients with Moderately to Severely Active Ulcerative Colitis or Crohn's Disease
Ronilda D'Cunha, Tofial Azam, Jasmina Kalabic, et al.
Clinical Rheumatology
|
February 4, 2014
Safety, effectiveness, and pharmacokinetics of adalimumab in children with polyarticular juvenile idiopathic arthritis aged 2 to 4 years
Daniel J Kingsbury, Brigitte Bader-Meunier, Gina Patel, et al.
Clinical Therapeutics
|
February 7, 2021
Pharmacokinetic Comparability of Risankizumab Formulations in Prefilled Syringe and Auto-injector for Subcutaneous Injection
Hoi-Kei Lon, Ling Cheng, Sai Nudurupati, et al.
The Journal of Rheumatology
|
September 3, 2018
Clinical Responses and Synovial Vascularity in Obese Rheumatoid Arthritis Patients Treated with Adalimumab and Methotrexate
Gurjit S Kaeley, Daryl K MacCarter, Aileen L Pangan, et al.
Rheumatology and Therapy
|
April 1, 2017
Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study
Filip Van den Bosch, Andrew J K Ostor, Siegfried Wassenberg, et al.
Rheumatology and Therapy
|
May 6, 2017
Erratum to: Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study
Filip Van den Bosch, Andrew J K Ostor, Siegfried Wassenberg, et al.
The Journal of Rheumatology
|
June 17, 2016
Methotrexate Dosage Reduction Upon Adalimumab Initiation: Clinical and Ultrasonographic Outcomes from the Randomized Noninferiority MUSICA Trial
Gurjit S Kaeley, Amy M Evangelisto, Midori J Nishio, et al.
Clinical Pharmacology in Drug Development
|
July 2, 2024
SERENE ER Analysis Part 2 SERENE-UC: Exposure-response Analysis of Higher Versus Standard Adalimumab Dosing Regimens for Patients with Moderately to Severely Active Ulcerative Colitis
Sven Stodtmann, Mong-Jen Chen, Ana Victoria Ponce-Bobadilla, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
JAMA
|
January 22, 2025
Risankizumab for Ulcerative Colitis-Reply
Edouard Louis, Jasmina Kalabic, Edward V Loftus
Journal of Comparative Effectiveness Research
|
August 22, 2018
Systematic review and network meta-analysis: effect of biologics on radiographic progression in rheumatoid arthritis
Erin Murray, Alexandra Ellis, Yekaterina Butylkova, et al.
Clinical Pharmacokinetics
|
December 20, 2024
Evaluation of the Effect of Risankizumab on the Pharmacokinetics of Cytochrome P450 Substrates in Patients with Moderately to Severely Active Ulcerative Colitis or Crohn's Disease
Ronilda D'Cunha, Tofial Azam, Jasmina Kalabic, et al.
Clinical Rheumatology
|
February 4, 2014
Safety, effectiveness, and pharmacokinetics of adalimumab in children with polyarticular juvenile idiopathic arthritis aged 2 to 4 years
Daniel J Kingsbury, Brigitte Bader-Meunier, Gina Patel, et al.
Clinical Therapeutics
|
February 7, 2021
Pharmacokinetic Comparability of Risankizumab Formulations in Prefilled Syringe and Auto-injector for Subcutaneous Injection
Hoi-Kei Lon, Ling Cheng, Sai Nudurupati, et al.
The Journal of Rheumatology
|
September 3, 2018
Clinical Responses and Synovial Vascularity in Obese Rheumatoid Arthritis Patients Treated with Adalimumab and Methotrexate
Gurjit S Kaeley, Daryl K MacCarter, Aileen L Pangan, et al.
Rheumatology and Therapy
|
April 1, 2017
Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study
Filip Van den Bosch, Andrew J K Ostor, Siegfried Wassenberg, et al.
Rheumatology and Therapy
|
May 6, 2017
Erratum to: Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study
Filip Van den Bosch, Andrew J K Ostor, Siegfried Wassenberg, et al.
The Journal of Rheumatology
|
June 17, 2016
Methotrexate Dosage Reduction Upon Adalimumab Initiation: Clinical and Ultrasonographic Outcomes from the Randomized Noninferiority MUSICA Trial
Gurjit S Kaeley, Amy M Evangelisto, Midori J Nishio, et al.
Clinical Pharmacology in Drug Development
|
July 2, 2024
SERENE ER Analysis Part 2 SERENE-UC: Exposure-response Analysis of Higher Versus Standard Adalimumab Dosing Regimens for Patients with Moderately to Severely Active Ulcerative Colitis
Sven Stodtmann, Mong-Jen Chen, Ana Victoria Ponce-Bobadilla, et al.
Page
of 4